Long-term follow-up study of early psychosis treatment
Part of Mental health clinical trials.
This study follows people who were part of an earlier research trial about medication management during their first psychotic episode. Researchers want to understand how those early treatment choices affected their recovery over the past 20 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You participated in a previous medication study (NCT00334035) for first-episode psychosis between 2006–2008
- You were diagnosed with schizophrenia or a related condition (schizophreniform disorder, schizoaffective disorder, brief psychotic disorder, or other psychosis)
- You were between 18 and 65 years old when you first enrolled in that earlier study
- You took antipsychotic medications for at least 12 months during the original trial
- You did not have a major relapse or worsening of symptoms at the time you started the original study, or your psychotic symptoms were controlled
- You are not currently taking clozapine, mood-stabilizing medications (lithium, valproate, carbamazepine), or long-acting depot injections
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who have had psychosis for less than 4 years to understand how their symptoms change over time and how they respond to treatment. By using brain scans and other tests, researchers hope to find better ways to personalize care for early psychosis.
This is an observational (non-intervention) study that follows adults with schizophrenia who are taking specific “atypical” antipsychotic medicines long-term. Researchers want to learn about patients’ experiences and outcomes while on these treatments.
This study follows people who have recently been diagnosed with a first episode of schizophrenia, schizoaffective disorder, or are at ultra-high risk for psychosis. Researchers want to learn more about how these conditions develop over time to improve early care and treatment.
This trial looks at people having a first psychotic episode who have not yet taken anti-psychotic medicine. It aims to see whether an early support approach can help, before other treatments become necessary.
This study looks at how psychosis symptoms and development change over time in children and teens. It may help doctors better understand different patterns of illness and how to support young people with these disorders.
This trial tests a new medication called SEP-363856 over a long period for people with schizophrenia who are currently stable. It looks at how well the drug works and its safety over time.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.